← Back to Search

Behavioral Intervention

Intervention arm for Depression

N/A
Waitlist Available
Led By Daniel V Vigo, MD, Lic. Psych, DrPH
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the phq-9 will be administered to both the intervention and control group at baseline and 30 days.
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if a mobile app can help university students with their mental health and substance use.

Eligible Conditions
  • Depression
  • Addiction
  • Alcoholism
  • Schizophrenia
  • Anxiety

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the phq-9 will be administered to both the intervention and control group at baseline and 30 days.
This trial's timeline: 3 weeks for screening, Varies for treatment, and the phq-9 will be administered to both the intervention and control group at baseline and 30 days. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Alcohol consumption risk from Baseline to Follow-up at 30 days
Mental Depression
Change in General anxiety symptomology from Baseline to Follow-up at 30 days
Secondary study objectives
Alcohol Use Disorder
Bulimia
Frequency of cannabis consumption
+7 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention armExperimental Treatment1 Intervention
Participants randomized into the intervention arm will be given immediate access to a fully functional version of the Minder app that includes baseline, interim and follow-up surveys and access to all app components and e-coaching.
Group II: Control armActive Control1 Intervention
Participants randomized into the control arm will be given access to a restricted version of the app that only includes access to a generic study introduction video and baseline and follow up survey assessments delivered via the app.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Minder
2022
N/A
~1490

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,465 Previous Clinical Trials
2,484,008 Total Patients Enrolled
43 Trials studying Depression
11,886 Patients Enrolled for Depression
Daniel V Vigo, MD, Lic. Psych, DrPHPrincipal InvestigatorUniversity of British Columbia
~483 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top